Skip to main content

March 2015

 

 

academics

 

Clinical research courses

Vacancies in KPSC for the post of Pharmacist (16 anticipated posts)

Applications are invited online only by `One Time Registration' system exclusively from qualified candidates for the under mentioned post. Candidates shall apply only through the online facility provided in the website of Kerala Public Service Commission.

Post: Pharmacist Gr-II

Job as Quality Assurance Expert/consultant (M.Pharm) at Indian Institute of Integrative Medicine

CSIR-Indian Institute of Integrative Medicine, Jammu, has created a State of the Art National Facility namely cGMP pilot Plant for Extraction, Formulation and Packaging of Traditional (ISM) Herbal Medicinal formulations to prepare formulations in the form of a tablet/capsule/liquid, of the extracts and botanical derived APIs for preclinical and clinical trials in accordance with the requirements of regulatory agencies to develop new rational drug formulations, desires to recruit Quality Assurance expert/consultant and Plant Operators on purely temporary basis in the Institute as under:-

Post: Quality Assurance Expert/consultant

Walk in interview for M.Pharm as Project Assistant in SCTIMST

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.
The Institute signifies the convergence of Medical Sciences and Technology and its mission is to enable the indigenous growth of biomedical technology, besides demonstrating high standards of patient care in medical specialties and evolving postgraduate training programs. It has a hospital for tertiary care of cardiovascular and neurological diseases, and research programmes in the areas of basic and applied medical sciences,  a Biomedical Technology Wing with facilities  and research programmes for developing medical  devices from a conceptual stage to commercialization, and The Achutha Menon Centre for Health Science Studies for training and research in public health.

For a DBT Project entitled “Mechanism of epileptogenesis in young and adult brain-Role of NMDA receptor subtypes in hippocampal neurons and astrocytes” (P-8084)

Post: Project Assistant

Require Sr.Executive/ Asst.Manager- Quality Control Department in Rubicon Research

Rubicon Research is a product development company based in Mumbai, India and is recognized as a world class outsourcing partner in pharmaceutical industry, serving Fortune 500 companies worldwide. We are a fast growing, young organization of 250 employees with significant experience in the field of formulation development and providing a full spectrum of development services from preformulation to registration. We also have our GMP manufacturing plant from where we provide commercial supply chain.

Post: Sr.Executive/ Asst.Manager- Quality Control Department

Vacancies for B.Pharm/D.Pharm as Logistic Manager, Consultant in National Health Mission

National Health Mission (NHM), Rajasthan State Health Society, invites applications for various positions of Managers/Consultants/Ofificers/Coordinators and Assistants at State HQ on contractual basis under National Rural Health Mission (NRHM) Rajasthan.

The details of various positions, required essential qualifications & experience, maximum age limit etc.are as under:

Post: Logistic Manager, Consultant

Opening for Medical Representative in Up man Placements

Themis Medicare is a joint venture pharmaceutical company, with Gedeon Richter Ltd., Hungary. The company in over three decades has made its presence felt in manufacturing and marketing innovative pharmaceutical products.
Themis Medicare has an expanding international portfolio of affiliates across the globe with a presence in 40 countries. Additionally, company is planning to enter all 29 EU countries, USA, Canada, Australia with its unique research formulations. A balanced geographical presence coupled with a strong product flow form a wide therapeutic range serve as the business building blocks of the company.

Post: Medical Representative

SIMULTANEOUS DETERMINATION OF ITOPRIDE HYDROCHLORIDE AND LANSOPRAZOLE IN SYNTHETIC MIXTURE USING SPECTROPHOTOMETRIC TECHNIQUE (FIRST ORDER DERIVATIVE METHOD

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
*Ashif I. Bhim1, Farhana V. Buchiy1, Hasumati A. Raj1, Vineet C. Jain2
1Department of Qaulity Assurane, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
2Department of Pharmacognocy, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
bhimiqbal23@gmail.com

ABSTRACT
A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Itopride Hydrochloride and Lansoprazole in synthetic mixture using first order derivative zero-crossing method. Itopride Hydrochlorideshowed zero crossing point at 278.12nmwhile Lansoprazole showed zero crossing point at 244.58nm. The dA/dλ was measured at 244.12 nm for Itopride Hydrochloride and 278.12nmfor Lansoprazole and calibration curves were plotted as dA/dλ versus concentration, respectively. The method was found to be linear (r2>0.999) in the range of 5-25μg/ml for Itopride Hydrochloride at 244.58nm. The linear correlation was obtained (r2>0.996) in the range of 5-25 μg/ml for Lansoprazole at 278.12 nm. The limit of determination was 0.155μg/ml and 0.059μg/ml forItopride Hydrochloride and Lansoprazole, respectively. The limit of quantification was 0.472μg/ml and 0.179μg/ml for Itopride Hydrochloride and Lansoprazolerespectively. The accuracy of these method were evaluated by recovery studies and good recovery result were obtained greater than 99% shows first order derivation zero crossing. The method was successfully applied for simultaneous determination of Itopride Hydrochloride and Lansoprazolein binary mixture.

The Ebola virus circulating in humans in West Africa is undergoing relatively few mutations, none of which suggest that it is becoming more severe or transmissible, according to a National Institutes of Health study in Science. The study compares virus sequencing data from samples taken from patients in Guinea (March 2014), Sierra Leone (June 2014) and Mali (November 2014).

PAREXEL International Corporation, a global clinical research organization, announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (QSI), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.  Pharmacovigilance refers to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.  The acquisition is expected to close in early April of 2015, subject to the satisfaction of closing conditions.

Novo Nordisk today announced the company will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight® offers purity, reliability, and enhanced portability, with the highest storage temperature for the longest period of time compared with other marketed recombinant Factor VIII products—up to 86 degrees F for 12 months. It can be kept at that temperature for up to 4 hours after reconstitution, giving it the longest postreconstitution storage time. Novoeight® offers purity through a 5-step purification process. It was shown to be safe and effective in clinical trials with zero inhibitors confirmed in 213 previously treated patients with hemophilia A. Novo Nordisk plans to make Novoeight® available by mid-April 2015.